Caris Life Sciences, Inc. 8-K

What Happened
Caris Life Sciences, Inc. (CAI) filed an 8‑K on June 5, 2026 reporting the results of its 2026 Annual Meeting of Shareholders held June 4, 2026. As of the April 9, 2026 record date, 282,662,545 shares were outstanding; 273,714,520 shares were represented at the meeting, constituting a quorum. Ten director nominees were elected to serve until the 2027 Annual Meeting, and shareholders ratified Deloitte & Touche LLP as the company’s independent registered public accounting firm for fiscal 2026.

Key Details

• Shares outstanding (record date, Apr 9, 2026): 282,662,545; shares represented at meeting: 273,714,520.
• Director election results (Votes For / Votes Withheld; broker non‑votes: 11,087,026 for each nominee):
  • David Dean Halbert: 216,983,424 For / 45,644,070 Withheld
  • Brian J. Brille: 216,953,607 For / 45,673,887 Withheld
  • Peter M. Castleman: 200,435,909 For / 62,191,585 Withheld
  • David Fredrickson: 228,579,061 For / 34,048,433 Withheld
  • Joseph E. Gilliam: 215,798,279 For / 46,829,215 Withheld
  • Jon S. Halbert: 215,600,787 For / 47,026,707 Withheld
  • Laura I. Johansen: 227,201,421 For / 35,426,073 Withheld
  • Dr. Lloyd B. Minor: 228,662,425 For / 33,965,069 Withheld
  • Danny Phillips: 214,817,153 For / 47,810,341 Withheld
  • Dr. Jeffrey Vacirca: 228,673,484 For / 33,954,010 Withheld
• Auditor ratification vote: Deloitte & Touche LLP ratified — 273,517,324 For; 60,882 Against; 136,314 Abstentions.

Why It Matters

• Board and governance: The election results confirm the company’s board composition for the coming year, with all ten nominees approved by shareholders. Vote totals show varying levels of withheld votes across nominees, which can signal differing shareholder support levels to monitor.
• Auditor continuity: Ratification of Deloitte & Touche LLP maintains continuity of the external audit for fiscal 2026, an important factor for financial reporting and investor confidence.
• Practical impact for investors: No changes to executive leadership or material transactions were reported in this filing; the 8‑K focuses on governance results from the annual meeting.